A new treatment called a “living drug” modifies immune cells of the patient and ‘teaches’ them to attack cancer cells. The drug known as CAR-T cell immunotherapy was approved by FDA to be used for children and young adults with ...

Writing in the journal Science Translational Medicine, a European team of researchers reports that two girls have remained cancer-free 18 and 12 months after being given a novel treatment, IFLScience reports. In this case, it involved genetically engineering white blood ...